Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
Factors associated with a successful outcome upon nucleos(t)ide analogue (NA) treatment withdrawal in HBeAg-negative chronic hepatitis B (CHB) patients have yet to be clarified. The objective of this study was to analyse the HBV-specific T cell response, in parallel with peripheral and intrahepatic...
| Autores: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Fecha de publicación: | 2021 |
| País: | España |
| Recursos: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:240174 |
| Acesso em linha: | https://ddd.uab.cat/record/240174 https://dx.doi.org/urn:doi:10.1016/j.jhep.2020.11.043 |
| Access Level: | acceso abierto |
| Palavra-chave: | Hepatitis B virus Chronic hepatitis B Nucleos(t)ide analogue Antiviral therapy discontinuation HBsAg HBcrAg Covalently closed circular DNA HBV-RNA Immune response HBV-Specific T cells |
| Resumo: | Factors associated with a successful outcome upon nucleos(t)ide analogue (NA) treatment withdrawal in HBeAg-negative chronic hepatitis B (CHB) patients have yet to be clarified. The objective of this study was to analyse the HBV-specific T cell response, in parallel with peripheral and intrahepatic viral parameters, in patients undergoing NA discontinuation. Twenty-seven patients without cirrhosis with HBeAg-negative CHB with complete viral suppression (. |
|---|